profluent.bioの競合サイトトップ10

synthego.com

This tech note takes a closer look at a new high throughput method to evaluate novel nucleases leveraging Synthego's Halo™ Platform for Synthetic sgRNA and automation capabilities coupled with Paragon Genomics' ClearPlex™ amplicon sequencing technology.

addgene.org

addgene, the nonprofit plasmid repository, accelerates science by sharing useful plasmid-based research materials, viral preps, and information worldwide.

crisprmedicinenews.com

Order here the special designed WeDoCRISPR Mask and join the global WDC community of students and young scientists working with CRISPR.

qb3.org

Read Courtney Strasenburgh’s original story on the Broad Stem Cell Center website. Two researchers at the Weill Institute for Neurosciences and the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF (Broad Stem Cell Center) have been awarded over $26 million in funding from the California Institute for Regenerative Medicine […]

proteindesign.org

The Huang lab specializes in designing new proteins and rewiring native ones. We use computational and experimental tools to study and use the principles of protein folding in our work.

vowst.com

stop recurrent c. diff from attacking again with vowst, the only fda-approved microbiome treatment in oral capsules that helps prevent c. diff from coming back again.

kymeratx.com

Kymera is a clinical stage company pioneering targeted protein degradation to deliver revolutionary treatments for patients around the world.

crisp-bio.blog.jp

CRISPRを介した転写の活性化と抑制（CRISPRaとCRISPRi）は、遺伝子発現を制御するための強力かつプログラム可能な手法である。細菌においてもCRISPRiは確立されたが、一方で、細菌内在の活性化ドメインが限られていることから、細菌におけるCRISPRaは期待通りには機能せず

newsroom.regeneron.com

The Investor Relations website contains information about Regeneron Pharmaceuticals Inc.'s business for stockholders, potential investors, and financial analysts.

ir.genmab.com

The Investor Relations website contains information about Genmab A/S's business for stockholders, potential investors, and financial analysts.